Journal of The Korean Dental Society of Anesthesiology (대한치과마취과학회지)

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지

Experience of a Bloodless Two-Jaw Surgery and Care in Jehovah's Witnesses with Anemia

빈혈이 있는 여호와의 증인 환자에서 무수혈 양악교정 수술

  • Lee, Jung-Man (Department of Dental Anesthesiology, Seoul National University Dental Hospital) ;
  • Seo, Kwang-Suk (Department of Dental Anesthesiology, Seoul National University Dental Hospital) ;
  • Kim, Hyun-Jeong (Department of Dental Anesthesiology, Seoul National University Dental Hospital) ;
  • Shin, Soon-Young (Department of Dental Anesthesiology, Seoul National University Dental Hospital)
  • 이정만 (서울대학교치과병원 치과마취과) ;
  • 서광석 (서울대학교치과병원 치과마취과) ;
  • 김현정 (서울대학교치과병원 치과마취과) ;
  • 신순영 (서울대학교치과병원 치과마취과)
  • Received : 2012.03.23
  • Accepted : 2012.03.30
  • Published : 2012.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

We report a case of 15 year-old Jehovah's Witness patient with mild anemia who underwent a successful orthognathic two-jaw surgery. Jehovah's Witness patients refuse transfusion of blood or blood products even in life threatening situations. The use of recombinant human erythropoietin and iron supplement increased hemoglobin during preoperative period. Intraoperatively, meticulous surgical hemostasis, acute normovolemic hemodilution and induced hypotension enabled the completion of the operation without the use of blood products.

Keywords

References

  1. Lee JH, Ahn W: The stance of Jehovah's Witnesses on the use blood and Hospital Liaison Committee. Korean J Anesthesiol 2011; 60(4):302. https://doi.org/10.4097/kjae.2011.60.4.302
  2. Stewart A, Newman L, Sneddon K, Harris M: Aprotinin reduces blood loss and the need for transfusion in orthognathic surgery. Br J Oral Maxillofac Surg 2001; 39(5): 365-70. https://doi.org/10.1054/bjom.2001.0664
  3. Benoist S, Panis Y, Pannegeon V, Alves A, Valleur P: Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery 2001; 129(4): 433-9. https://doi.org/10.1016/S0039-6060(01)77381-3
  4. Aderinto J, Brenkel IJ: Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br 2004; 86(7): 970-3. https://doi.org/10.1302/0301-620X.86B7.14682
  5. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, et al: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 1989; 111(12): 992-1000. https://doi.org/10.7326/0003-4819-111-12-992
  6. Goodnough LT, Skikne B, Brugnara C: Erythropoietin, iron, and erythropoiesis. Blood 2000; 96(3): 823-33.
  7. Singh H, Reed J, Noble S, Cangiano JL, Van Wyck DB: Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. Clin J Am Soc Nephrol 2006; 1(3): 475-82. https://doi.org/10.2215/CJN.01541005
  8. Zijp IM, Korver O, Tijburg LB: Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr 2000; 40(5): 371-98. https://doi.org/10.1080/10408690091189194
  9. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, et al: Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354(9194): 1940-7. https://doi.org/10.1016/S0140-6736(99)01264-7
  10. Peters DC, Noble S: Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 1999; 57(2): 233-60. https://doi.org/10.2165/00003495-199957020-00015
  11. Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, et al: Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet 2000; 355(9212): 1303-9. https://doi.org/10.1016/S0140-6736(00)02111-5
  12. Litvan H, Santacana E, Casas JI, Aris A, Villar Landeira JM: Aprotinin therapy to reduce blood loss in Jehovah's Witnesses. Can J Anaesth 1994; 41(1): 77-8. https://doi.org/10.1007/BF03009674
  13. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al: A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358(22): 2319-31. https://doi.org/10.1056/NEJMoa0802395
  14. Wang G, Bainbridge D, Martin J, Cheng D: The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109(2): 320-30. https://doi.org/10.1213/ane.0b013e3181aa084c
  15. 이종현, 신다흰, 허금주, 이창하, 나찬영: 무수혈 심장 수술에 대한 임상적 고찰. 대한마취과학회지 2007; 52: 530-6.
  16. Nagy CJ, Wheeler AS, Archer TL: Acute normovolemic hemodilution, intraoperative cell salvage and PulseCO hemodynamic monitoring in a Jehovah's Witness with placenta percreta. Int J Obstet Anesth 2008; 17(2): 159-63. https://doi.org/10.1016/j.ijoa.2007.07.005
  17. Schaller RT Jr, Schaller J, Morgan A, Furman EB: Hemodilution anesthesia: a valuable aid to major cancer surgery in children. Am J Surg 1983; 146(1): 79-84. https://doi.org/10.1016/0002-9610(83)90263-5
  18. O'Connor PJ, Hanson J, Finucane BT: Induced hypotension with epidural/general anesthesia reduces transfusion in radical prostate surgery. Can J Anaesth 2006; 53(9): 873-80. https://doi.org/10.1007/BF03022829
  19. Paul JE, Ling E, Lalonde C, Thabane L: Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth 2007; 54(10): 799-810. https://doi.org/10.1007/BF03021707
  20. 이성진, 이기영, 서봉수, 남용택: 유도 저혈압하 양악 교정수술 시 급성 동량성 혈액희석이 출혈량과 수혈량에 미치는 영향. Korean J Anesthesiol 2004; 46: 690-5. https://doi.org/10.4097/kjae.2004.46.6.690
  21. Michelson AD, MacGregor H, Barnard MR, Kestin AS, Rohrer MJ, Valeri CR: Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 1994; 71(5): 633-40.
  22. Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg H, et al: Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology 1996; 85(5): 1043-8; discussion 30A-31A. https://doi.org/10.1097/00000542-199611000-00012